THE EFFECT OF AGE AND EVERYDAY EXERCISE ON STEADY-STATE PLASMA DIGOXIN CONCENTRATIONS

被引:0
作者
TEAGUE, AC
GARNETT, WR
BRIGGS, GC
STANLEY, HR
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARM & PHARMACEUT,RICHMOND,VA 23298
[2] MCGUIRE HUNTER HOLMES VET AFFAIRS MED CTR,DEPT GERIATR MED,RICHMOND,VA
来源
PHARMACOTHERAPY | 1995年 / 15卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Age-related physiologic changes may significantly alter the disposition and pharmacologic characteristics of many drugs, The elderly are the most frequent users of digoxin because of increased prevalence of atrial fibrillation and congestive heart failure. This study was conducted to confirm the decrease in digoxin concentrations during exercise, to determine if age is a factor in this decrease, and to explore the difference between chronologic age and physiologic age. Eighteen men age 50-85 years were treated with digoxin for more than 1 month before enrolling and had serum digoxin concentrations of 0.4-2.0 mu g/L. They were evaluated during a 3-hour period in the morning (A.M. dose withheld). Blood samples were obtained every 10 minutes during sequential 60-minute periods of rest (phase I), walking (phase II), and rest (phase III). There were no significant differences in mean concentration between phases II and I (p<0.76), phases III and phase I (p<0.70), or phases II and III (p<0.37). The effect of age was positively correlated with the mean concentration of phase II but was not statistically significant (p<0.62). Statistically significant correlations were seen only between the exercise phase and serum albumin and Mini-Mental Status Examination scores. We conclude that exercise has minimal, if any, clinically relevant effects on plasma digoxin concentrations. Increasing chronologic age has no influence on a decrease in the concentrations with exercise; a younger physiologic age may play a role.
引用
收藏
页码:502 / 508
页数:7
相关论文
共 30 条
[1]   PHARMACOKINETIC INVESTIGATIONS IN ELDERLY PATIENTS - CLINICAL AND ETHICAL CONSIDERATIONS [J].
ABERNETHY, DR ;
AZARNOFF, DL .
CLINICAL PHARMACOKINETICS, 1990, 19 (02) :89-93
[2]   COMPARISON OF ENALAPRIL VERSUS DIGOXIN FOR CONGESTIVE HEART-FAILURE [J].
BEAUNE, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (08) :D22-D25
[3]  
BOTKER HE, 1991, BRIT HEART J, V65, P337
[4]   DISTRIBUTION AND CONCENTRATION OF TRITIATED DIGOXIN IN HUMAN TISSUES [J].
DOHERTY, JE ;
PERKINS, WH ;
FLANIGAN, WJ .
ANNALS OF INTERNAL MEDICINE, 1967, 66 (01) :116-+
[5]   MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].
FOLSTEIN, MF ;
FOLSTEIN, SE ;
MCHUGH, PR .
JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198
[6]  
GIBSON TC, 1965, CHRON DIS, P797
[7]   THE EFFECT OF EVERYDAY EXERCISE ON STEADY-STATE DIGOXIN CONCENTRATIONS [J].
HALL, PD ;
GARNETT, WR ;
KOLB, KW ;
ROCK, WL ;
STANLEY, H .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (12) :1083-1088
[8]   INFLUENCE OF EVERYDAY PHYSICAL-ACTIVITY ON THE SERUM DIGOXIN CONCENTRATION IN DIGOXIN-TREATED PATIENTS [J].
JOGESTRAND, T .
CLINICAL PHYSIOLOGY, 1981, 1 (02) :209-214
[9]   EFFECT OF PHYSICAL EXERCISE ON THE PHARMACOKINETICS OF DIGOXIN DURING MAINTENANCE TREATMENT [J].
JOGESTRAND, T ;
ANDERSSON, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 (01) :73-76
[10]   DIGOXIN CONCENTRATION IN RIGHT ATRIAL MYOCARDIUM, SKELETAL-MUSCLE AND SERUM IN MAN - INFLUENCE OF ATRIAL RHYTHM [J].
JOGESTRAND, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (04) :243-250